000 | 01017 a2200301 4500 | ||
---|---|---|---|
005 | 20250513145514.0 | ||
264 | 0 | _c19980729 | |
008 | 199807s 0 0 eng d | ||
022 | _a0003-9926 | ||
024 | 7 |
_a10.1001/archinte.158.13.1469-a _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDooley, D P | |
245 | 0 | 0 |
_aRevisiting doxycycline. _h[electronic resource] |
260 |
_bArchives of internal medicine _cJul 1998 |
||
300 |
_a1469-70 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xeconomics |
650 | 0 | 4 |
_aAzithromycin _xtherapeutic use |
650 | 0 | 4 |
_aDoxycycline _xeconomics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPatient Compliance |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 |
_aUrethritis _xdrug therapy |
650 | 0 | 4 |
_aUterine Cervicitis _xdrug therapy |
773 | 0 |
_tArchives of internal medicine _gvol. 158 _gno. 13 _gp. 1469-70 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/archinte.158.13.1469-a _zAvailable from publisher's website |
999 |
_c9631339 _d9631339 |